Home | Welcome to Contract Pharma   
Last Updated Saturday, March 28 2015

Print

Search Results for 'Financial Report: Alkermes'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published March 9, 2015
Streamlines manufacturing ops into Athlone and Wilmington facilities Read More »
Published February 23, 2015
Namchuk responsible for advancing the early-stage product pipeline Read More »
Published October 31, 2014
Revenues up 14% in the quarter Read More »
Published April 30, 2014
Manufacturing and royalty revenues down 24% in the quarter Read More »
By Gil Roth
Published January 6, 2014
Expects to begin trials of MS prodrug in mid-2014 Read More »
Published October 31, 2013
Revenues up 13%, loss narrows Read More »
Published July 25, 2013
Key commercial products up 22% in the quarter Read More »
Alkermes
By Fidelma Callanan, Sr. Director Marketing and Commercial Development
Four decades delivering contract pharma solutions for our Partners Alkermes Contract Pharma Services provid… Read More »
By Zohrab Bostanian, President & CEO
By Tim McLaughlin, Vice President, Business Development


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On